SOPH — SOPHiA GENETICS SA
—
Nasdaq ·
Information Technology ·
IT Services ·
CIK 1840706 ·
Last close
$8.49
Market Cap
$722.74M
52W High
$8.98
52W Low
$3.75
ADV30
656,726
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 23,310,000 | 15,061,000 | -20,053,000 | -22,356,000 | 198,359,000 | 107,665,000 | 115,241,000 |
| Mar 2026 | 21,688,000 | 14,749,000 | -17,283,000 | -19,322,000 | 156,995,000 | 65,392,000 | 111,307,000 |
| Dec 2025 | 21,707,000 | 14,692,000 | -18,516,000 | -19,179,000 | 163,031,000 | 70,289,000 | 115,886,000 |
| Sep 2025 | 19,462,000 | 12,907,000 | -17,862,000 | -20,021,000 | 163,458,000 | 81,610,000 | 102,771,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-39,741,000
Investing CF
$-11,126,000
Financing CF
$64,660,000
CapEx
$-10,720,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-1.15
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-560,954,000
Inventory
$7,084,000
Receivables
$14,112,000
ST Investments
—
EBIT TTM
$-73,677,000
Pretax Income TTM
$-80,300,000
Interest Exp TTM
$6,623,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$86,167,000
EBITDA
$-71,746,000
Free Cash Flow
$-25,659,124
Enterprise Value
$624,117,952
Total Cash
$107,665,000
Total Debt
$61,827,000
Shares Out
85,127,825
Trailing EPS
$-1.16
Book Value
$0.98
ROE
-101.2%
ROA
-24.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 77,271,000 | -70,906,000 | -78,999,000 | 163,031,000 | 115,886,000 | 47,145,000 | -35,893,000 |
| Dec 2024 | 65,173,000 | -66,568,000 | -62,493,000 | 155,309,000 | 58,819,000 | 96,490,000 | -44,515,000 |
| Dec 2023 | 62,371,000 | -74,826,000 | -78,981,000 | 206,156,000 | 54,714,000 | 151,442,000 | -53,224,000 |
| Dec 2022 | 47,560,000 | -87,823,000 | -87,449,000 | 243,838,000 | 43,708,000 | 200,130,000 | -70,093,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.50
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $8.49 · call volume: 112 · put volume: 1Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| YALA | Yalla Group Ltd | $695.21M | $5.47 | — |
| PUBM | PubMatic, Inc. | $686.76M | $18.41 | — |
| SMWB | SIMILARWEB LTD. | $669.81M | $7.59 | — |
| OSPN | OneSpan Inc. | $658.92M | $17.88 | — |
| DDI | DoubleDown Interactive Co., Ltd. | $648.65M | $13.09 | — |
News headlines (Yahoo Finance, 1h cache)
SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise
2026-09-04 13:08 · Yahoo
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript
2026-08-11 16:46 · Yahoo
SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics
2026-08-05 09:45 · Yahoo
Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ...
2026-08-04 19:00 · Yahoo
SOPHiA GENETICS Q2 Earnings Call Highlights
2026-08-04 18:04 · Yahoo
SOPH Stock Heads For Best Day In Over 8 Months – What’s Driving Today’s Super Rally?
2026-08-04 15:23 · Yahoo
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026
2026-07-21 12:00 · Yahoo
Is SOPHiA GENETICS SA (SOPH) Among the Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On?
2026-06-23 19:38 · Yahoo
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
2026-06-22 12:25 · Yahoo
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
2026-06-19 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.